Síndrome del intestino irritable y enfermedad inflamatoria intestinal: ¿alguna conexión?

[1]  X. Badia,et al.  Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria , 2012, PharmacoEconomics.

[2]  D. Drossman,et al.  Functional Bowel Disorders , 1995, The American Journal of Gastroenterology.

[3]  J. Lloreta,et al.  Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis , 2009, Scandinavian journal of gastroenterology.

[4]  A. Schoepfer,et al.  Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies , 2008, Inflammatory bowel diseases.

[5]  J. Peyron,et al.  Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome , 2007, Gut.

[6]  M. Osterman.  Immune Activation in Patients With Irritable Bowel Syndrome , 2008 .

[7]  F. Casellas,et al.  Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum , 2006, Gut.

[8]  L. Lix,et al.  The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome? , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  J. Panés,et al.  Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. , 2006, Gastroenterology.

[10]  F. Farrokhyar,et al.  Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health , 2006, Inflammatory bowel diseases.

[11]  M. Simrén,et al.  Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis , 2006, Scandinavian journal of gastroenterology.

[12]  H. Verspaget,et al.  Role of Tumor Necrosis Factor-α and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome , 2005, The American Journal of Gastroenterology.

[13]  M. Simrén,et al.  A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  S. Collins,et al.  Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. , 2005, Gastroenterology.

[15]  F. Mearin,et al.  Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. , 2005, Gastroenterology.

[16]  F. Shanahan,et al.  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. , 2005, Gastroenterology.

[17]  A. Weston,et al.  Terminal ileal mucosal mast cells in irritable bowel syndrome , 1993, Digestive Diseases and Sciences.

[18]  H. Verspaget,et al.  Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. , 2005, The American journal of gastroenterology.

[19]  O. Mickisch,et al.  Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. , 2005, Clinical laboratory.

[20]  P. Venge,et al.  Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome , 2004, Gut.

[21]  Wang Lh,et al.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004 .

[22]  X-C Fang,et al.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004, Gut.

[23]  W. Khan,et al.  Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. , 2004, Gastroenterology.

[24]  B. Oldenburg,et al.  IBS-Like Symptoms in Patients with Inflammatory Bowel Disease in Remission; Relationships with Quality of Life and Coping Behavior , 2004, Digestive Diseases and Sciences.

[25]  D. Santini,et al.  Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.

[26]  X. Badia,et al.  Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria , 2004, American Journal of Gastroenterology.

[27]  R. Spiller,et al.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.

[28]  R. Spiller.  Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective. , 2003 .

[29]  Y. Joo,et al.  Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. , 2003, Journal of Korean medical science.

[30]  N. Read,et al.  Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome , 2003, Gut.

[31]  X. Badia,et al.  Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype , 2003, European journal of gastroenterology & hepatology.

[32]  D. Drossman,et al.  Inflammatory bowel disease versus irritable bowel syndrome: a hospital‐based, case‐control study of disease impact on quality of life , 2003, Scandinavian journal of gastroenterology.

[33]  P. Whorwell,et al.  Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? , 2003, Gut.

[34]  R. Spiller.  Postinfectious irritable bowel syndrome. , 2003, Gastroenterology.

[35]  B. Nyberg,et al.  Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. , 2002, Gastroenterology.

[36]  G. Barbara,et al.  A role for inflammation in irritable bowel syndrome? , 2002, Gut.

[37]  S. Collins.  A case for an immunological basis for irritable bowel syndrome. , 2002, Gastroenterology.

[38]  Wangxue Chen,et al.  Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.

[39]  Clifford Goodman,et al.  The burden of selected digestive diseases in the United States. , 2002, Gastroenterology.

[40]  E. Björnsson,et al.  Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors , 2002, American Journal of Gastroenterology.

[41]  R. Spiller,et al.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.

[42]  C. O'Morain,et al.  Increased mast cells in the irritable bowel syndrome , 2000, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[43]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[44]  N. Read,et al.  The role of psychological and biological factors in postinfective gut dysfunction , 1999, Gut.

[45]  N. Read,et al.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea , 1996, The Lancet.

[46]  K. Mchugh,et al.  Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. , 1995, Gastroenterology.

[47]  L. Melton,et al.  Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. , 1995, American journal of epidemiology.

[48]  J. Salzmann,et al.  Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[49]  K. Heaton,et al.  Towards positive diagnosis of the irritable bowel. , 1978, British medical journal.